MXPA01005818A - Composicion y metodo para la regulacion del peso del cuerpo y condiciones asociadas. - Google Patents

Composicion y metodo para la regulacion del peso del cuerpo y condiciones asociadas.

Info

Publication number
MXPA01005818A
MXPA01005818A MXPA01005818A MXPA01005818A MXPA01005818A MX PA01005818 A MXPA01005818 A MX PA01005818A MX PA01005818 A MXPA01005818 A MX PA01005818A MX PA01005818 A MXPA01005818 A MX PA01005818A MX PA01005818 A MXPA01005818 A MX PA01005818A
Authority
MX
Mexico
Prior art keywords
regulation
composition
body weight
associated conditions
conditions
Prior art date
Application number
MXPA01005818A
Other languages
English (en)
Inventor
Miles B Brennan
Original Assignee
Eleanor Rooseveltl Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/374,827 external-priority patent/US6603058B1/en
Application filed by Eleanor Rooseveltl Inst filed Critical Eleanor Rooseveltl Inst
Publication of MXPA01005818A publication Critical patent/MXPA01005818A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
MXPA01005818A 1998-12-09 1999-12-09 Composicion y metodo para la regulacion del peso del cuerpo y condiciones asociadas. MXPA01005818A (es)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US11158198P 1998-12-09 1998-12-09
US14630199P 1999-07-29 1999-07-29
US14630699P 1999-07-29 1999-07-29
US14630299P 1999-07-29 1999-07-29
US14630399P 1999-07-29 1999-07-29
US14630499P 1999-07-29 1999-07-29
US14630599P 1999-07-29 1999-07-29
US14630099P 1999-07-29 1999-07-29
US14629999P 1999-07-29 1999-07-29
US09/374,827 US6603058B1 (en) 1998-12-09 1999-08-12 Non-human animal model for obesity and uses thereof
PCT/US1999/029337 WO2000033658A1 (en) 1998-12-09 1999-12-09 Composition and method for regulation of body weight and associated conditions

Publications (1)

Publication Number Publication Date
MXPA01005818A true MXPA01005818A (es) 2003-07-21

Family

ID=27581011

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01005818A MXPA01005818A (es) 1998-12-09 1999-12-09 Composicion y metodo para la regulacion del peso del cuerpo y condiciones asociadas.

Country Status (6)

Country Link
EP (1) EP1137340A4 (es)
JP (1) JP2003520015A (es)
AU (1) AU3117600A (es)
CA (1) CA2353776A1 (es)
MX (1) MXPA01005818A (es)
WO (1) WO2000033658A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002064091A2 (en) 2001-02-13 2002-08-22 Palatin Technologies, Inc. Melanocortin metallopeptides for treatment of sexual dysfunction
AU2001257420A1 (en) * 2000-04-28 2001-11-12 Zengen, Inc. A gene therapy system and method using alpha-MSH and its derivatives
CA2415938A1 (en) 2000-07-14 2002-01-24 Zycos Inc. Alpha-msh related compounds and methods of use
CA2422068A1 (en) * 2000-09-13 2002-03-21 Eleanor Roosevelt Institute Method for treatment of insulin resistance in obesity and diabetes
AU2004251616A1 (en) * 2003-06-19 2005-01-06 Eli Lilly And Company Melanocortin receptor 4(MC4) agonists and their uses
WO2005000338A1 (en) * 2003-06-19 2005-01-06 Eli Lilly And Company Uses of melanocortin-3 receptor (mc3r) agonist peptides
FR2857873B1 (fr) * 2003-07-21 2006-02-24 Courtage Et De Diffusion Codif Procede et produit cosmetique destines a limiter la croissance des tissus adipeux
CA2557739A1 (en) * 2004-03-29 2005-11-03 Eli Lilly And Company Uses of melanocortin-4 receptor (mc4r) agonist peptides administered by continuous infusion
TWI352736B (en) * 2004-04-08 2011-11-21 Astellas Pharma Inc New compound
WO2005118573A1 (en) 2004-05-28 2005-12-15 Smithkline Beecham Corporation Novel diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors
US7169773B2 (en) 2004-07-01 2007-01-30 Smithkline Beecham Corporation Compounds
CA2585287A1 (en) 2004-10-25 2006-05-04 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
US7910101B2 (en) 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
WO2006073771A2 (en) * 2005-01-05 2006-07-13 Eli Lilly And Company Polyethylene glycol linked mc4r or mc3r agonist peptides
US7790671B2 (en) * 2005-10-07 2010-09-07 Codman & Shurtleff, Inc. Implantable pump for protein delivery for obesity control by drug infusion into the brain
CA2725143A1 (en) 2008-05-21 2009-11-26 Neurotez, Inc. Methods for treating progressive cognitive disorders related to neurofibrillary tangles
EP2352510A4 (en) 2008-11-04 2012-08-29 Neurotez Inc LEPTIN COMPOSITIONS AND METHODS OF TREATING PROGRESSIVE COGNITIVE DISORDERS DUE TO THE ASSEMBLY OF NEUROFIBRILLARY BUNNELS AND AMYLOID BETA

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100048A (en) * 1992-04-10 2000-08-08 Oregon Health Sciences University Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
US5932779A (en) * 1996-06-10 1999-08-03 Millennium Pharmaceuticals, Inc. Screening methods for compounds useful in the regulation of body weight

Also Published As

Publication number Publication date
AU3117600A (en) 2000-06-26
JP2003520015A (ja) 2003-07-02
EP1137340A4 (en) 2005-12-21
CA2353776A1 (en) 2000-06-15
EP1137340A1 (en) 2001-10-04
WO2000033658A1 (en) 2000-06-15

Similar Documents

Publication Publication Date Title
ZA9711421B (en) Method and compositions for weight control
MXPA01005818A (es) Composicion y metodo para la regulacion del peso del cuerpo y condiciones asociadas.
PL352014A1 (en) Dietetic of pharmacological composition for preventing or treating hyperoxaluria
SG71862A1 (en) Composition and method for inhibiting the growth of microorganisms including stabilized sodium hypobromite and isothiazolones
EP1143987A4 (en) NATURAL COMPOSITION AND METHOD FOR TREATING SEXUAL DYSFUNCTIONS
HK1048232A1 (en) Method for improving the skin and coat of pets
MX203651B (en) Cationic electrocoating compositions, method of making, and use
AU3497295A (en) Compositions and methods for the treatment of body weight disorders, including obesity
ZA971964B (en) Azolobenzazepine derivatives and compositions and method of use thereof.
HU9802721D0 (en) Method and composition for the treatment and prevention of hyperuricemia
ZA991053B (en) Method and composition for treatment of inflammatory conditions.
GB9827500D0 (en) Compounds for control of eating, growth and body weight
AU7755398A (en) Method for reducing body weight
EP1127860A4 (en) PYROTECHNIC COMPOSITION AND METHOD FOR MANUFACTURING THE SAME
GB9814733D0 (en) Method of reducing or preventing malodour
HUP9904243A3 (en) Method for inhibiting the expression of fas
EP0915706A4 (en) EXAMINATION METHODS FOR COMPOUNDS THAT CAN REGULATE BODY WEIGHT
GB9814732D0 (en) Method of reducing or preventing malodour
EP1007726A4 (en) METHOD AND COMPOSITIONS FOR REGULATING GENE EXPRESSION
EP1096927A4 (en) STRESS TREATMENT COMPOSITION
IL137439A0 (en) Method for the determination of prosthetic infections
HU9900436D0 (en) Installation and method for the treatment of wine-production efilvents
IL120285A (en) Process for the preparation of 1,5-benzothiazepine derivatives, process for the preparation of the intermediate thereof and an intermediate thereof
GB2352450B (en) Method for producing of 2,3-dimethylbutene-1 and 2,3-dimethylbutene-2
GB9814731D0 (en) Method of reducing or preventing malodour

Legal Events

Date Code Title Description
FA Abandonment or withdrawal